Cargando…

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme

Glioblastoma multiforme is an aggressive cancer type with poor patient outcomes. Interestingly, we reported previously a novel association between the little studied paucimannosidic N-linked glycoepitope and glioblastoma. Paucimannose has only recently been detected in vertebrates where it exhibits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Becker, Yvonne, Förster, Sarah, Gielen, Gerrit H., Loke, Ian, Thaysen-Andersen, Morten, Laurini, Christine, Wehrand, Kristin, Pietsch, Torsten, Diestel, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633888/ https://www.ncbi.nlm.nih.gov/pubmed/31320997 http://dx.doi.org/10.18632/oncotarget.27056

Ejemplares similares

Role of Lamin A/C as Candidate Biomarker of Aggressiveness and Tumorigenicity in Glioblastoma Multiforme
por: Gatti, Giuliana, et al.
Publicado: (2021)

High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan
por: Bigotti, Maria Giulia, et al.
Publicado: (2021)

Cerebral Organoids Maintain the Expression of Neural Stem Cell-Associated Glycoepitopes and Extracellular Matrix
por: Roll, Lars, et al.
Publicado: (2022)

Lectin-Based Study Reveals the Presence of Disease-Relevant Glycoepitopes in Bladder Cancer Cells and Ectosomes
por: Surman, Magdalena, et al.
Publicado: (2022)

Tegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycans
por: Garcia-Campos, Andres, et al.
Publicado: (2016)

Reduced paucimannosidic N‐glycan formation by suppression of a specific β‐hexosaminidase from Nicotiana benthamiana
por: Shin, Yun‐Ji, et al.
Publicado: (2016)

Tsetse salivary glycoproteins are modified with paucimannosidic N-glycans, are recognised by C-type lectins and bind to trypanosomes
por: Kozak, Radoslaw P., et al.
Publicado: (2021)

Complementary LC-MS/MS-Based N-Glycan, N-Glycopeptide, and Intact N-Glycoprotein Profiling Reveals Unconventional Asn71-Glycosylation of Human Neutrophil Cathepsin G
por: Loke, Ian, et al.
Publicado: (2015)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Conserved topology of virus glycoepitopes presents novel targets for repurposing HIV antibody 2G12
por: Miller, Nathaniel L., et al.
Publicado: (2022)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

β-N-Acetylhexosaminidases HEXO1 and HEXO3 Are Responsible for the Formation of Paucimannosidic N-Glycans in Arabidopsis thaliana
por: Liebminger, Eva, et al.
Publicado: (2011)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

HGG-34. DETECTION OF ONCOGENIC FUSION EVENTS IN SUPRATENTORIAL GLIOBLASTOMAS OF YOUNG CHILDREN
por: Pietsch, Torsten, et al.
Publicado: (2020)

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme
por: Lickliter, Jason D., et al.
Publicado: (2023)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Analysis of Staphylococcus aureus wall teichoic acid glycoepitopes by Fourier Transform Infrared Spectroscopy provides novel insights into the staphylococcal glycocode
por: Grunert, Tom, et al.
Publicado: (2018)

miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2
por: Chung, Hyun Joo, et al.
Publicado: (2015)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Targeting Metabolic Remodeling in Glioblastoma Multiforme
por: Wolf, Amparo, et al.
Publicado: (2010)

Glioblastoma Multiforme Oncogenomics and Signaling Pathways
por: Kanu, Okezie O., et al.
Publicado: (2009)

Glioblastoma Multiforme: Novel Therapeutic Approaches
por: Fialho, Arsenio M., et al.
Publicado: (2012)

Pediatric Cerebellar Hemorrhagic Glioblastoma Multiforme
por: Kalina, Peter
Publicado: (2012)

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q77ek342a5g8kp9c8fucm84muk